Get the Stockscreener App
6.39
0.63%
0.04
Treace Medical Concepts Inc stock is traded at $6.39, with a volume of 201.42K.
It is up +0.63% in the last 24 hours and down -4.77% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$6.35
Open:
$6.33
24h Volume:
201.42K
Relative Volume:
0.63
Market Cap:
$403.68M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-6.2512
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-6.99%
1M Performance:
-4.77%
6M Performance:
-9.75%
1Y Performance:
+37.12%
1-Day Range:
$6.23
$6.45
1-Week Range:
$6.23
$6.92
52-Week Range:
$4.66
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
6.39 | 401.15M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Y Intercept Hong Kong Ltd Raises Stake in Treace Medical Concepts, Inc. $TMCI - MarketBeat
What catalysts could drive Treace Medical Concepts Inc. stock higher2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
Why Treace Medical Concepts Inc. stock could be next big winnerJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Is Treace Medical Concepts Inc. stock trading at a premium valuation2025 Market Trends & Community Consensus Stock Picks - newser.com
Volume spikes in Treace Medical Concepts Inc. stock – what they mean2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Real time social sentiment graph for Treace Medical Concepts Inc.Quarterly Market Review & Low Volatility Stock Recommendations - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Developing predictive dashboards with Treace Medical Concepts Inc. dataWatch List & Real-Time Buy Signal Alerts - newser.com
Can trapped investors hope for a rebound in Treace Medical Concepts Inc.Risk Management & Weekly High Conviction Ideas - newser.com
How risky is Treace Medical Concepts Inc. stock nowShare Buyback & Precise Trade Entry Recommendations - newser.com
Price momentum metrics for Treace Medical Concepts Inc. explainedAnalyst Downgrade & Smart Allocation Stock Tips - newser.com
Will Treace Medical Concepts Inc. stock benefit from infrastructure spendingPortfolio Value Summary & Daily Entry Point Alerts - newser.com
Published on: 2025-11-01 06:43:14 - newser.com
Treace Medical Concepts Inc.’s volatility index tracking explainedTrade Volume Summary & Accurate Trade Setup Notifications - newser.com
Why Treace Medical Concepts Inc. stock could benefit from AI revolutionTrade Volume Report & Weekly High Potential Stock Alerts - newser.com
Published on: 2025-10-31 00:30:23 - newser.com
Multi factor analysis applied to Treace Medical Concepts Inc.2025 Market Overview & Community Consensus Stock Picks - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Published on: 2025-10-30 09:48:27 - newser.com
Important Notice to Long-Term Shareholders of Amylyx - GlobeNewswire
Treace Medical’s Innovative Foot Correction Study: A Potential Game-Changer? - MSN
Treace Medical Concepts (TMCI) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Published on: 2025-10-29 21:39:54 - newser.com
Will Treace Medical Concepts Inc. price bounce be sustainableTrade Performance Summary & Daily Market Momentum Tracking - newser.com
Treace Medical (TMCI) insider filing shows 208-share move - Stock Titan
TMCI insider Form 4: 984 shares disposed, 548,281 owned post-trade - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Published on: 2025-10-28 00:55:17 - newser.com
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
14.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):